These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells. Das R; Mahabeleshwar GH; Kundu GC J Biol Chem; 2003 Aug; 278(31):28593-606. PubMed ID: 12771144 [TBL] [Abstract][Full Text] [Related]
4. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. Chakraborty G; Rangaswami H; Jain S; Kundu GC J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305 [TBL] [Abstract][Full Text] [Related]
7. Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation. Rangaswami H; Bulbule A; Kundu GC J Biol Chem; 2004 Sep; 279(37):38921-35. PubMed ID: 15247285 [TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase and NF-kappaB regulate motility of invasive MDA-MB-231 human breast cancer cells by the secretion of urokinase-type plasminogen activator. Sliva D; Rizzo MT; English D J Biol Chem; 2002 Feb; 277(5):3150-7. PubMed ID: 11689575 [TBL] [Abstract][Full Text] [Related]
9. c-Src-dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. Huang WC; Chen JJ; Chen CC J Biol Chem; 2003 Mar; 278(11):9944-52. PubMed ID: 12645577 [TBL] [Abstract][Full Text] [Related]
10. Protein kinase C induces motility of breast cancers by upregulating secretion of urokinase-type plasminogen activator through activation of AP-1 and NF-kappaB. Sliva D; English D; Lyons D; Lloyd FP Biochem Biophys Res Commun; 2002 Jan; 290(1):552-7. PubMed ID: 11779207 [TBL] [Abstract][Full Text] [Related]
11. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. Das R; Mahabeleshwar GH; Kundu GC J Biol Chem; 2004 Mar; 279(12):11051-64. PubMed ID: 14704150 [TBL] [Abstract][Full Text] [Related]
12. Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells. Mahabeleshwar GH; Kundu GC J Biol Chem; 2003 Feb; 278(8):6209-21. PubMed ID: 12477728 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of I kappa B alpha activates NF kappa B through a redox-regulated and c-Src-dependent mechanism following hypoxia/reoxygenation. Fan C; Li Q; Ross D; Engelhardt JF J Biol Chem; 2003 Jan; 278(3):2072-80. PubMed ID: 12429743 [TBL] [Abstract][Full Text] [Related]
14. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase. Takada Y; Mukhopadhyay A; Kundu GC; Mahabeleshwar GH; Singh S; Aggarwal BB J Biol Chem; 2003 Jun; 278(26):24233-41. PubMed ID: 12711606 [TBL] [Abstract][Full Text] [Related]
15. Temporal pattern of NFkappaB activation influences apoptotic cell fate in a stimuli-dependent fashion. Fan C; Yang J; Engelhardt JF J Cell Sci; 2002 Dec; 115(Pt 24):4843-53. PubMed ID: 12432072 [TBL] [Abstract][Full Text] [Related]
16. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis. Manna SK; Aggarwal BB J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874 [TBL] [Abstract][Full Text] [Related]
18. Identification of a p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in down-regulation of NF-kappaB-mediated gene expression and up-regulation of apoptosis. Takada Y; Singh S; Aggarwal BB J Biol Chem; 2004 Apr; 279(15):15096-104. PubMed ID: 14711835 [TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation-dependent activation of NFkappaB is compromised in T cells from the elderly. Ponnappan S; Uken-Trebilcock G; Lindquist M; Ponnappan U Exp Gerontol; 2004 Apr; 39(4):559-66. PubMed ID: 15050291 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. Sasaki CY; Barberi TJ; Ghosh P; Longo DL J Biol Chem; 2005 Oct; 280(41):34538-47. PubMed ID: 16105840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]